quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 11, 2026

Deep Sea Minerals Corp. Provides Strategic Update on Cook Islands and U.S. NOAA Pathways as U.S. Accelerates Offshore Critical Minerals Policy and Expands Supply-Chain Investment

View original at globenewswire.com
Deep Sea Minerals Corp. Provides Strategic Update on Cook Islands and U.S. NOAA Pathways as U.S. Accelerates Offshore Critical Minerals Policy and Expands Supply-Chain Investment Vancouver, BC, Feb…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The NOAA-administered pathway is distinct from international seabed regimes due to its integration with U.S. supply chain policy, national security priorities, and federally funded seabed mapping programs.

    80% confidence
  • NOAA permitting modernization and expanded mapping activity signal increased U.S. institutional momentum toward identifying and enabling future offshore critical minerals options.

    80% confidence
  • Increased industry attention to NOAA-administered pathways further supports the view that the U.S. regulatory channel is becoming a focal point for offshore critical minerals strategy.

    80% confidence
  • The Cook Islands' relevance as a seabed minerals jurisdiction was further reinforced in February 2026, when the Cook Islands Government and the United States formalized a framework for cooperation on critical minerals research and supply chain security, reflecting increased alignment with U.S.-led critical minerals policy objectives.

    80% confidence
  • Critical mineral supply chains are increasingly being treated as strategic infrastructure.

    80% confidence
  • The Cook Islands extending aspects of its seabed minerals exploration program timeline reinforces the importance of rigorous data review, stakeholder engagement, and careful sequencing for any future offshore initiatives.

    80% confidence
  • The U.S. regulatory framework entered a material inflection point in January 2026, when NOAA announced revisions intended to modernize and consolidate the DSHMRA permitting process, followed by the launch of a federally funded hydrographic survey exceeding 30,000 square nautical miles offshore American Samoa.

    80% confidence
  • Graduating to the OTCQB is an important milestone for Deep Sea Minerals as we continue to advance our strategy and broaden our exposure to U.S. investors. We believe this listing enhances our visibility and accessibility in the U.S. market and supports our ongoing efforts to build long-term shareholder value.

    80% confidence
  • U.S. critical minerals stockpiling and supply chain actions (Project Vault) underscore the accelerating policy focus on securing reliable, scalable critical mineral access and reducing exposure to concentrated processing and supply risks.

    80% confidence
  • The aggressive action taken by the U.S. Government in recent weeks reinforces the critical minerals imperative and validates our strategic focus. The institutional momentum is profound. U.S. collaboration with the Cook Islands Government attests to the nation's critical minerals importance, consistent with Deep Sea's evaluation of this area.

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com